Infectología pediátrica Enfoque Orientado a Problemas. Moffe

584

Capítulo 20  Infección por VIH y sida

REFERENCIAS SELECCIONADAS https://aidsinfo.nih.gov/guidelines/html/2/pediatric-treat- ment-guidelines/0# (Guidelines for the use of antiretrovi- ral agents in pediatric HIV infection) Abay SM, Deribe K, Reda AA, et al. The effect of early ini- tiation of antiretroviral therapy in TB/HIV coinfected patients: a systematic review and meta-analysis. J Int Assoc Provid AIDS Care 2015;14:560–70. American Academy of Pediatrics. Committee on Pediatric AIDS. Disclosure of illness status to children and adoles- cents with HIV infection. Pediatrics 1999;103:164–6. American Academy of Pediatrics. Committee on Pediatric AIDS and Committee on Infectious Diseases. Issues related to human immunodeficiency virus transmission in schools, child care, medical settings, the home, and com- munity. Pediatrics 1999;104:318–24. Brouwers P, Civitelo L, DeCarli C, et al. Cerebrospinal fluid viral load is related to cortical atrophy and not to intra- cerebral calcifications in children with symptomatic HIV disease. J Neurovirol 2000;6:390–7. Centers for Disease Control and Prevention. Updated guide- lines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States. 2016. http://www.cdc. gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines. pdf, accessed October 24, 2016. Chelucci C, Federico M, Guerriero R, et al. Productive human immunodeficiency virus-1 infection of purified mega- karyocytic progenitors/precursors and maturing mega- karyocytes. Blood 1998;91:1225–34. Chiappini E, Berti E, Gianesin K, et al. Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era. Cancer Lett 2014;347:38–45. Cohen S, Ter Stege JA, Geurtsen GU, et al. Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls. Clin Infect Dis 2015;60:1111–9. Cole JL, Marzec UM, Gunthel CJ, et al. Ineffective platelet production in thrombocytopenic human immunodefi- ciency virus-infected patients. Blood 1998;91:3239–46. Connor EM, Sperling RS, Gelber R, et al. Reduction of mater- nal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173–80. Fisher RG, Nageswaran S, Valentine ME, et al. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. AIDS Patient Care STDS 2001;15:263–9. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999;341:441–3. Gerson AC, Joyner M, Fosarelli P, et al. Disclosure to HIV diag- nosis to children: when, where, why, and how. J Pediatr Health Care 2001;15:161–7. Koenig HC, Garland JM, Weissman D, et al. Vaccinating HIV patients: focus on human papillomavirus and herpes zos- ter vaccines. AIDS Rev 2013;15:77–86.

Liliang PC, Liang CL, Chang WN, et al. Use of ventriculo- peritoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal men- ingitis without hydrocephalus. Clin Infect Dis 2002;34: e64–8. Mauss S, Corzillius M, Wolf E, et al. Risk factors for the HIV- associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Med 2002;3:49–55. Miller TL, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics 2001;108:1287–96. Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. MMWR Recomm Rep 2009;58:1–166. Mofensen LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS clinical trials group study 185 team. N Engl J Med 1999;341:385–93. Moore DAJ, Benepal T, Portsmouth S, et al. Etiology and natural history of neutropenia in human immunodefi- ciency virus disease: a prospective study. Clin Infect Dis 2001;32:469–76. Paterson DL, Swindells S, Mohr J, et al. Adherence to prote- ase inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21–30. Roubenoff R, Schmitz H, Bairos L, et al. Reduction of abdomi- nal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle. Clin Infect Dis 2002;34:390–3. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompro- mised host. Clin Infect Dis 2013:1–57. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome. Emer­ gence of a unique syndrome during highly active antiret- roviral therapy. Medicine 2002;81:213–27. Shingadia D. Viani RM. Yogev R, et al. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics 2000;105:e80. Shivakoti R, Yang WT, Gupte N, et al. Concurrent anemia and elevated C-reactive protein predicts HIV clinical treat- ment failure, including tuberculosis, after antiretroviral therapy initiation. Clin Infect Dis 2015;61:102–10. Steele AD, Madhi SA, Louw CE, et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatr Infect Dis J 2011;30:125–30. Sullivan P. Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. J Infect Dis 2002;185(Suppl 2):S138–42.

Wilcox CM, Alexander LN, Clark WS, et al. Fluconazole compared with endoscopy for human immunodeficiency virus-infectedpatientswith esophageal symptoms. Gastro‑ enterology 1996;110:1803–9. AMPLE